Taken together, these data support the idea that the DUSP14-ACOX1-PA-β-catenin axis plays a crucial role in CRC progression and that Nu-7441 may be a potential strategy for the treatment of CRC by inhibiting the DUSP14-ACOX1-PA-β-catenin axis. The gene discussed is DUSP14; the disease is colorectal carcinoma.